Active Not Recruiting OBSERVATIONAL NCT06597045
BIOMARKER and IMAGING CHARACTERISATION of INFLAMMATORY ATHEROMA in PATIENTS RECEIVING IMMUNOTHERAPY and ANGIOGENESIS INHIBITORS (BIOCAPRI)
Sponsor: NHS Greater Glasgow and Clyde
Conditions
Atherosclerotic Disease Cancer Cardiotoxicity
Interventions
PET/CT with 18-FDG
Updated 1 time since 2024 Last updated: Sep 11, 2024 Started: Aug 30, 2022 Primary completion: Oct 14, 2024 Completion: Nov 20, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This observational or N/A phase trial investigates Atherosclerotic Disease and Cancer and is currently ongoing. NHS Greater Glasgow and Clyde leads this study, which shows 1 recorded version since 2022 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
1 version recorded Active Not Recruiting
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- NHS Greater Glasgow and Clyde
- Roche Diagnostics GmbH
- University of Glasgow
Data source: NHS Greater Glasgow and Clyde
For direct contact, visit the study record on ClinicalTrials.gov .